Considering that NF-κB pathway has been implicated in the induction of inflammatory mediators and aberrant NF-κB activation can contribute to the initiation and progression of atherosclerosis [20], we thus hypothesized whether the activation of NF-κB pathway was involved in miR-26a-induced anti-inflammatory response in atherosclerosis. Here, NFKB1 is linked to atherosclerosis.